Trinity Biotech Retained Earnings (Accumulated Deficit) 2010-2024 | TRIB

Trinity Biotech retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Trinity Biotech Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-49
2022 $-27
2021 $13
2020 $11
2019 $16
2018 $55
2017 $76
2016 $110
2015 $209
2014 $191
2013 $176
2012 $166
2011 $150
2010 $-21
2009 $-87
Trinity Biotech Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-62
2024-06-30 $-58
2024-03-31 $-51
2023-12-31 $-49
2023-09-30 $-42
2023-06-30 $-36
2023-03-31 $-31
2022-12-31 $-27
2022-09-30 $-18
2022-06-30 $-9
2022-03-31 $0
2021-12-31 $13
2021-09-30 $14
2021-06-30 $12
2021-03-31 $13
2020-12-31 $11
2020-09-30 $16
2020-06-30 $8
2020-03-31 $9
2019-12-31 $16
2019-09-30 $50
2019-06-30 $50
2019-03-31 $55
2018-12-31 $55
2018-09-30 $48
2018-06-30 $47
2018-03-31 $47
2017-12-31 $76
2017-09-30 $90
2017-06-30 $91
2017-03-31 $93
2016-12-31 $110
2016-09-30 $197
2016-06-30 $198
2016-03-31 $199
2015-12-31 $209
2015-09-30 $199
2015-06-30 $191
2015-03-31 $188
2014-12-31 $191
2014-09-30 $179
2014-06-30 $179
2014-03-31 $174
2013-12-31 $176
2013-09-30 $163
2013-06-30 $163
2013-03-31 $164
2012-12-31 $166
2012-09-30 $155
2012-06-30 $151
2012-03-31 $151
2011-12-31 $150
2011-09-30 $145
2011-06-30 $144
2011-03-31 $142
2010-12-31 $-21
2010-09-30 $-29
2010-06-30 $-33
2010-03-31 $-84
2009-12-31 $-87
2009-09-30 $-91
2009-06-30 $-94
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.000B $0.057B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.797B 24.85
Boston Scientific (BSX) United States $139.837B 40.20
Stryker (SYK) United States $139.395B 31.41
EssilorLuxottica (ESLOY) France $110.104B 0.00
Medtronic (MDT) Ireland $103.429B 15.36
Lonza Group Ag (LZAGY) Switzerland $43.664B 0.00
Haleon (HLN) United Kingdom $41.193B 26.76
GE HealthCare Technologies (GEHC) United States $38.725B 20.09
ResMed (RMD) United States $34.324B 28.21
Terumo (TRUMY) Japan $28.025B 39.58
Koninklijke Philips (PHG) Netherlands $24.269B 18.58
Zimmer Biomet Holdings (ZBH) United States $20.811B 13.25
Insulet (PODD) United States $19.068B 75.93
Baxter (BAX) United States $15.022B 9.77
Smith & Nephew SNATS (SNN) United Kingdom $10.471B 0.00
Bio-Rad Laboratories (BIO) United States $9.568B 32.52
BellRing Brands (BRBR) United States $9.145B 36.79
Demant (WILYY) Denmark $8.596B 0.00
Lantheus Holdings (LNTH) United States $6.666B 15.49
Haemonetics (HAE) United States $3.851B 18.79
ICU Medical (ICUI) United States $3.779B 35.98
Prestige Consumer Healthcare (PBH) United States $3.656B 18.18
Perrigo (PRGO) Ireland $3.326B 9.79
Envista Holdings (NVST) United States $3.198B 23.82
QuidelOrtho (QDEL) United States $3.077B 19.81
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
Neogen (NEOG) United States $2.678B 30.90
GN Store Nord (GNNDY) Denmark $2.593B 16.63
LeMaitre Vascular (LMAT) United States $2.104B 51.14
Green Thumb Industries (GTBIF) United States $1.564B 27.37
AtriCure (ATRC) United States $1.531B 0.00
AdaptHealth (AHCO) United States $1.364B 9.75
InMode (INMD) Israel $1.335B 8.03
BioLife Solutions (BLFS) United States $1.234B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.225B 0.00
Owens & Minor (OMI) United States $1.071B 8.37
Curaleaf Holdings (CURLF) Canada $0.942B 0.00
Phibro Animal Health (PAHC) United States $0.812B 14.32
CeriBell (CBLL) United States $0.750B 0.00
Evolus (EOLS) United States $0.633B 0.00
Capricor Therapeutics (CAPR) United States $0.600B 0.00
VAREX IMAGING (VREX) United States $0.551B 24.31
Surmodics (SRDX) United States $0.549B 0.00
Omeros (OMER) United States $0.512B 0.00
Cresco Labs (CRLBF) United States $0.459B 0.00
Verano Holdings (VRNOF) United States $0.423B 0.00
ZimVie (ZIMV) United States $0.372B 31.37
Valneva SE (VALN) France $0.369B 0.00
Quanterix (QTRX) United States $0.363B 0.00
Viemed Healthcare (VMD) United States $0.310B 29.44
Biote (BTMD) United States $0.307B 6.73
Cerus (CERS) United States $0.293B 0.00
Sanara MedTech (SMTI) United States $0.282B 0.00
OraSure Technologies (OSUR) United States $0.270B 18.10
Canopy Growth (CGC) Canada $0.267B 0.00
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.249B 52.20
Aurora Cannabis (ACB) Canada $0.227B 0.00
Sanuwave Health (SNWV) United States $0.224B 3.15
Utah Medical Products (UTMD) United States $0.207B 14.26
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.198B 0.00
Brainsway (BWAY) Israel $0.177B 94.00
TerrAscend (TSNDF) Canada $0.164B 0.00
TriSalus Life Sciences (TLSI) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.137B 17.21
Quipt Home Medical (QIPT) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.126B 0.00
Veru (VERU) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 10.88
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
InterCure (INCR) Israel $0.076B 0.00
INLIF (INLF) $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Exagen (XGN) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.046B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.30
SNDL (SNDL) Canada $0.000B 0.00